NCT05264714View on ClinicalTrials.gov

Cluster Headache Treatment With Rimegepant

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Cluster Headache

Interventions

DRUG

Rimegepant

150 mg oral disintegrating tablet every other day for one week

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT05264714 - Cluster Headache Treatment With Rimegepant | Biotech Hunter | Biotech Hunter